By Dr Alys Havard

Conference Presentations

Robijn A; Tran DT; Cohen JM; Donald S; Cesta CE; Furu K; Parkin L; Pearson SA; Reutfors J; Zoega H; Zwar N; Havard A, 2024, 'Effectiveness of prescription smoking cessation pharmacotherapies during pregnancy: a multi-national study', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024

Zhou J; Varney B; Bharat C; Degenhardt L; Jones N; Havard A; Tran DT, 2024, 'Retention in opioid agonist treatment following childbirth and associated factors', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=97s

Tran D; Varney B; Jones N; Bharat C; Brett J; Oei J; Pearson SA; Degenhardt L; Havard A, 2024, 'Trends in the use of opioid agonist treatment for opioid dependence in pregnancy', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=1850s

Varney B; Bharat C; Brett J; Degenhardt L; Jones N; Oei J; Pearson SA; Havard A; Tran DT, 2024, 'Use of opioid agonist therapy in pregnancy: Timing of initiation and treatment retention', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=2664s

Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M; de Oliveira Costa J, 2023, 'Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues', presented at Australian Diabetes Congress 2023

Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)', presented at 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2023

Back to profile page